MarketInOut Stock Screener Log In | Sign Up
 

Johnson & Johnson

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 06/05/2026
Johnson & Johnson stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization537,387 mln
Float2,403 mln
Earnings Date07/15/2026

EPS

8.64
Strong

P / E

26.94
Elevated

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.08
Caution advised

1-Year Forecast

253
Modest upside

Relative Strength

72 / 100
Outperforming

Business Description

Johnson & Johnson is a global healthcare company founded in 1886 and headquartered in New Brunswick, New Jersey. Through its Innovative Medicine division, it develops and sells prescription treatments across a wide range of medical conditions, including cancer, immune disorders, and heart disease. Its MedTech division supplies medical devices and technologies used in surgery, joint care, eye health, and other clinical settings, serving hospitals, clinics, and healthcare professionals around the world.

Key Fundamentals

EPS8.64
P/E26.94
ROE26.39
RPS39.59
ROIC14.32
ROA10.73
Interest Cover24.82
EBITDA, mln33,714
EV / EBITDA17.39
EV / EBIT22.57
Revenue, mln96,362
EV / Revenue6.08

Financial Strength

Altman Z-Score3.69
Piotroski F-Score 4 / 9
Beneish M-Score-2.08
Price to Intrinsic Value2.04
Price to Lynch Fair Value2.05
1-Year Target Price253
Shiller PE Ratio28.05
Short Ratio2.96
Short % of Float1.07

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.3% 92 / 100   
1 Month 4.22% 88 / 100   
2 Months -5.76% 24 / 100   
6 Months 14.62% 77 / 100   
1 Year 55.72% 88 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us